ProShare Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $567K | Sell |
|
|||||
|
2025
Q1 | $609K | Sell |
|
|||||
|
2024
Q4 | $537K | Sell |
|
|||||
|
2024
Q3 | $749K | Sell |
|
|||||
|
2024
Q2 | $734K | Sell |
|
|||||
|
2024
Q1 | $951K | Buy |
|
|||||
|
2023
Q4 | $802K | Sell |
|
|||||
|
2023
Q3 | $797K | Buy |
|
|||||
|
2023
Q2 | $891K | Sell |
|
|||||
|
2023
Q1 | $1.11M | Sell |
|
|||||
|
2022
Q4 | $1.66M | Sell |
|
|||||
|
2022
Q3 | $1.71M | Buy |
|
|||||
|
2022
Q2 | $1.67M | Sell |
|
|||||
|
2022
Q1 | $2.06M | Sell |
|
|||||
|
2021
Q4 | $2.77M | Sell |
|
|||||
|
2021
Q3 | $3.6M | Buy |
|
|||||
|
2021
Q2 | $3.02M | Buy |
|
|||||
|
2021
Q1 | $2.41M | Sell |
|
|||||
|
2020
Q4 | $3.08M | Buy |
|